Site ES34017

Barcelona 08003

1 studies enrolling now · 2 studies all time

What they study most

Anaplastic Lymphoma Kinase (ALK) Positive, Non-small Cell Lung Cancer (NSCLC), Urothelial Cancer

Studies at this site

• A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC) — Recruiting now
• Enfortumab Vedotin and Pembrolizumab vs. Chemotherapy Alone in Untreated Locally Advanced or Metastatic Urothelial Cancer — Running, not enrolling